IFNB1 and neoplasm: Immunotherapy, such as high-dose interferon beta or interferon alfa-2b, has been shown to improve disease control and survival; however, the toxicities related to the dosage of these drugs remain disputed.8-10 Our patient underwent complete excision of the tumor in 2009 and had recurrent disease in 2012, for which he had surgery twice.